Sociedad Quimica y Minera stock price target raised by BofA to $43.50

Sociedad Quimica y Minera (SQM) reported robust Q2 2025 results, significantly exceeding EPS and revenue estimates, amid a 28% August stock rally driven by improved lithium price sentiment. BofA Securities subsequently raised its price target to $43.50 from $36.50. However, the firm maintained its 'Underperform' rating, citing concerns over SQM's current valuation being excessive relative to peers, an unfavorable risk/return profile, and the stock pricing in 2026 lithium prices well above spot, despite current market momentum and recent financial strength.

Analysis

Sociedad Quimica y Minera (SQM) has demonstrated significant fundamental strength, reporting Q2 2025 revenue of $2.08 billion and EPS of $0.79, substantially outperforming analyst estimates of $1.08 billion and $0.58, respectively. This robust performance is mirrored in its market momentum, with the stock rallying 28% in August, outpacing the 16% rise in Chinese spot lithium carbonate prices. Despite this positive backdrop and a shift in investor sentiment from bearish to bullish, BofA Securities maintains a cautious stance. While raising its price target to $43.50, the firm reiterated its "Underperform" rating, signaling that the stock's current price of $46.65 may be overextended. BofA's caution is rooted in several specific risks: an unattractive valuation relative to peers, the stock pricing in 2026 lithium prices well above current spot levels, and the dependency of further commodity price gains on additional Chinese supply cuts. Furthermore, ongoing mid-term risks associated with SQM's Codelco deal contribute to an unfavorable risk/return profile at current trading levels.

Key Decisions for Investors

• Given that SQM's stock price of $46.65 is trading above BofA's newly raised $43.50 price target, investors should weigh the company's strong recent earnings beat against the analyst's view that the valuation has become excessive.
• It is critical to monitor spot lithium prices and news of any further supply cuts in China, as BofA identifies these as key dependencies for justifying the stock's current premium.
• Investors should scrutinize SQM's valuation against its direct competitors and assess the long-term implications of the Codelco partnership, which BofA highlights as a persistent mid-term risk.